Marlborough

Boston Scientific of Marlborough has won federal regulatory approval for an implantable medical device that helps patients at high risk for stroke, the company said.

At the end of 2005, Boston Scientific Corp. made the fateful choice to buy cardiovascular equipment company Guidant Corp. for $27 billion. Since then, repercussions from the acquisition have weighed on the Marlborough-based medical device company. But with the settlement of a lawsuit over the deal in February, the company seems to be moving forward.

Medical diagnostics firm Oxford Immunotec of Marlborough finished last year with a 19-percent year-over-year increase in revenue in the fourth quarter, part of a 28-percent jump for the entire year, the company reported Tuesday.

Boston Scientific has agreed to acquire the urology division of American Medical Systems for about $1.6 billion in cash, the Marlborough-based life sciences company announced Monday morning.

American Tower Corp. announced Thursday that it is raising over $3 billion in a stock offering that will help finance fulfilling a contract with Verizon.

Sunovion Pharmaceuticals of Marlborough announced the start of a phase 3 clinical trial program for SUN-101, an inhalation solution being investigated for the treatment of chronic obstructive pulmonary disease (COPD).

Marlborough's Ocata Therapeutics (formerly Advanced Cell Technology), said it has been awarded two new U.S. patents for its cell therapy technology to treat ophthalmic, autoimmune and inflammatory diseases.

It's no secret that 2014 was a good year for the MetroWest commercial office market around Interstate...

Health care organizations of all kinds are striving for efficiency under the looming transition to managed-care systems.Instead of being paid for each service, providers will instead be paid to deliver care for a set number of patients annually. Naturally, this is leading providers to reconsider how they manage those patients from the moment they walk through the door.

Talk to technology entrepreneurs and there's a question that often comes up: Would you rather do cool stuff or important stuff? Make an amazing virtual reality headset or improve the treatment options for diabetes? ReWalk Robotics doesn't have to choose.